表紙:スマート吸入器市場- 製品別、適応疾患別、流通チャネル別- 世界予測、2023-2032年
市場調査レポート
商品コード
1396578

スマート吸入器市場- 製品別、適応疾患別、流通チャネル別- 世界予測、2023-2032年

Smart Inhalers Market - By Product, By Disease Indication, By Distribution Channel - Global Forecast, 2023-2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 135 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.74円
スマート吸入器市場- 製品別、適応疾患別、流通チャネル別- 世界予測、2023-2032年
出版日: 2023年10月17日
発行: Global Market Insights Inc.
ページ情報: 英文 135 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スマート吸入器市場規模は、世界の呼吸器疾患の急増に起因して、2023年から2032年にかけてCAGR 8.6%で拡大します。

喘息や慢性閉塞性肺疾患(COPD)のような疾患の負担の増加に伴い、高度な呼吸ケアソリューション、特にスマート吸入器の需要が急増しています。2023年のCDCの報告によると、COPDは米国で毎年1,600万人以上が罹患しています。スマート吸入器は、投与量のリマインダーやリアルタイムのモニタリングなどの機能を通じて、服薬アドヒアランスの向上を提供します。さらに、遠隔医療や遠隔患者モニタリングを取り入れるヘルスケアの状況により、市場は大きな勢いを増すと見られています。

業界は製品、適応疾患、流通チャネル、地域に区分されます。

製品別では、MDIベースのスマート吸入器市場が2022年に大きな牽引力を獲得し、2032年までの成長率は9.1%になると予測されています。MDIベースのスマート吸入器は、服薬アドヒアランスとモニタリングを強化するために、従来の吸入デバイスと技術を統合しています。これらのスマート吸入器はまた、全体的な呼吸管理を改善するために、リアルタイムのデータ追跡、投与リマインダー、患者のためのパーソナライズされた洞察を促進します。MDIデバイスのユーザーフレンドリーな性質は、デジタル接続の利点と組み合わされて、セグメントの成長にも寄与します。

流通チャネルの面では、呼吸器疾患の負担増と便利なヘルスケアソリューションへの嗜好の高まりに起因して、eコマースセグメントのスマート吸入器市場は2023年から2032年の間に10%のCAGRでかなりの収益を上げると予測されます。製品の比較、ユーザーレビューの閲覧、情報の入手がオンラインで簡単にできることが、消費者の意思決定の強化につながっています。さらに、デジタルヘルスと遠隔医療の動向の高まりが、このセグメントの拡大に拍車をかけそうです。

地域的には、欧州のスマート吸入器産業は2023-2032年にCAGR 8.9%で力強い成長を示すことになります。洗練されたヘルスケアインフラの存在と、この地域における呼吸器疾患の高い有病率が、革新的な呼吸器ケアソリューションの採用を促進しています。さらに、喘息やCOPDの効果的な管理のためのデジタル技術と統合されたスマート吸入器の開発のための製薬会社や技術企業による継続的な投資は、患者関与イニシアチブの増加とともに、地域の産業拡大を加速します。例えば、2023年7月、Teva社は、喘息やCOPDに苦しむ患者のために、デジタル技術を活用した新しい吸入器を英国で発表しました。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 スマート吸入器の業界洞察

  • COVID-19の影響分析
  • エコシステム分析
  • 技術情勢
  • 規制状況
  • 業界への影響要因
    • 促進要因
      • 世界の呼吸器疾患の流行
      • スマート吸入器の技術的進歩
      • 製薬会社とソフトウェア会社のパートナーシップ契約の増加
      • 医療アドヒアランスの向上
    • 業界の潜在的リスク&課題
      • 発展途上国における認知度の低さ
      • 重大なセキュリティリスクとプライバシー問題
  • 成長可能性分析
  • ポーターの分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
    • Adherium
    • GlaxoSmithKline Plc
    • Novartis AG
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニング・マトリックス
  • 戦略展望マトリックス

第5章 スマート吸入器の市場規模・予測:製品別、2018年~2032年

  • 主要動向:製品別
  • ドライパウダー吸入器(DPI)ベースのスマート吸入器
  • 定量吸入器(MDI)ベースのスマート吸入器

第6章 スマート吸入器の市場規模・予測:適応疾患別、2018年~2032年

  • 主要動向:適応疾患別
  • 喘息
  • 慢性閉塞性肺疾患

第7章 スマート吸入器の市場規模・予測:流通チャネル別、2018年~2032年

  • 主要動向:流通チャネル別
  • 病院薬局
  • 小売薬局
  • eコマース

第8章 スマート吸入器の市場規模・予測:地域別、2018年~2032年

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • トルコ
    • その他中東とアフリカ

第9章 企業プロファイル

  • Adherium
  • Propeller Health
  • Nemera
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Aptar Group Inc.
  • AstraZeneca Plc
  • Findair Sp. Z.o.o.
  • BioCorp
  • Zeolr Technologies Pvt Ltd.
  • Vectura Group Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
図表

Data Tables

  • TABLE 1. Industry impact forces
  • TABLE 2. Competitive analysis of major market players
  • TABLE 3. Competitive positioning matrix: Classification criteria
  • TABLE 4. DPI-based smart inhalers market size, 2018 - 2024 (USD Million)
  • TABLE 5. DPI-based smart inhalers market size, 2025 - 2032 (USD Million)
  • TABLE 6. MDI-based smart inhalers market size, 2018 - 2024 (USD Million)
  • TABLE 7. MDI-based smart inhalers market size, 2025 - 2032 (USD Million)
  • TABLE 8. Asthma market size, 2018 - 2024 (USD Million)
  • TABLE 9. Asthma market size, 2025 - 2032 (USD Million)
  • TABLE 10. Chronic obstructive pulmonary disease (COPD) market size, 2018 - 2024 (USD Million)
  • TABLE 11. Chronic obstructive pulmonary disease (COPD) market size, 2025 - 2032 (USD Million)
  • TABLE 12. Hospital pharmacies market size, 2018 - 2024 (USD Million)
  • TABLE 13. Hospital pharmacies market size, 2025 - 2032 (USD Million)
  • TABLE 14. Retail pharmacies market size, 2018 - 2024 (USD Million)
  • TABLE 15. Retail pharmacies market size, 2025 - 2032 (USD Million)
  • TABLE 16. E-commerce diseases indications market size, 2018 - 2024 (USD Million)
  • TABLE 17. E-commerce diseases indications market size, 2025 - 2032 (USD Million)
  • TABLE 18. North America smart inhalers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 19. North America smart inhalers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 20. North America smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 21. North America smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 22. North America smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 23. North America smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 24. North America smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 25. North America smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 26. U.S. smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 27. U.S. smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 28. U.S. smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 29. U.S. smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 30. U.S. smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 31. U.S. smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 32. Canada smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 33. Canada smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 34. Canada smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 35. Canada smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 36. Canada smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 37. Canada smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 38. Europe smart inhalers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 39. Europe smart inhalers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 40. Europe smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 41. Europe smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 42. Europe smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 43. Europe smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 44. Europe smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 45. Europe smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 46. Germany smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 47. Germany smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 48. Germany smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 49. Germany smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 50. Germany smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 51. Germany smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 52. UK smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 53. UK smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 54. UK smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 55. UK smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 56. UK smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 57. UK smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 58. France smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 59. France smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 60. France smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 61. France smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 62. France smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 63. France smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 64. Italy smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 65. Italy smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 66. Italy smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 67. Italy smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 68. Italy smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 69. Italy smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 70. Spain smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 71. Spain smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 72. Spain smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 73. Spain smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 74. Spain smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 75. Spain smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 76. Rest of Europe smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 77. Rest of Europe smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 78. Rest of Europe smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 79. Rest of Europe smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 80. Rest of Europe smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 81. Rest of Europe smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 82. Asia Pacific smart inhalers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 83. Asia Pacific smart inhalers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 84. Asia Pacific smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 85. Asia Pacific smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 86. Asia Pacific smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 87. Asia Pacific smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 88. Asia Pacific smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 89. Asia Pacific smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 90. China smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 91. China smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 92. China smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 93. China smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 94. China smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 95. China smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 96. Japan smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 97. Japan smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 98. Japan smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 99. Japan smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 100. Japan smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 101. Japan smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 102. India smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 103. India smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 104. India smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 105. India smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 106. India smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 107. India smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 108. Australia smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 109. Australia smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 110. Australia smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 111. Australia smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 112. Australia smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 113. Australia smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 114. Rest of Asia Pacific smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 115. Rest of Asia Pacific smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 116. Rest of Asia Pacific smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 117. Rest of Asia Pacific smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 118. Rest of Asia Pacific smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 119. Rest of Asia Pacific smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 120. Latin America smart inhalers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 121. Latin America smart inhalers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 122. Latin America smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 123. Latin America smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 124. Latin America smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 125. Latin America smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 126. Latin America smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 127. Latin America smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 128. Brazil smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 129. Brazil smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 130. Brazil smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 131. Brazil smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 132. Brazil smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 133. Brazil smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 134. Mexico smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 135. Mexico smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 136. Mexico smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 137. Mexico smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 138. Mexico smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 139. Mexico smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 140. Rest of Latin America smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 141. Rest of Latin America smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 142. Rest of Latin America smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 143. Rest of Latin America smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 144. Rest of Latin America smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 145. Rest of Latin America smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 146. Middle East & Africa smart inhalers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 147. Middle East & Africa smart inhalers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 148. Middle East & Africa smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 149. Middle East & Africa smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 150. Middle East & Africa smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 151. Middle East & Africa smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 152. Middle East & Africa smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 153. Middle East & Africa smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 154. South Africa smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 155. South Africa smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 156. South Africa smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 157. South Africa smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 158. South Africa smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 159. South Africa smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 160. Saudi Arabia smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 161. Saudi Arabia smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 162. Saudi Arabia smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 163. Saudi Arabia smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 164. Saudi Arabia smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 165. Saudi Arabia smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 166. Turkey smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 167. Turkey smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 168. Turkey smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 169. Turkey smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 170. Turkey smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 171. Turkey smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 172. Rest of Middle East & Africa smart inhalers market size, by product, 2018- 2024 (USD Million)
  • TABLE 173. Rest of Middle East & Africa smart inhalers market size, by product, 2025- 2032 (USD Million)
  • TABLE 174. Rest of Middle East & Africa smart inhalers market size, by diseases indication, 2018 - 2024 (USD Million)
  • TABLE 175. Rest of Middle East & Africa smart inhalers market size, by diseases indication, 2025 - 2032 (USD Million)
  • TABLE 176. Rest of Middle East & Africa smart inhalers market size, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 177. Rest of Middle East & Africa smart inhalers market size, by distribution channel, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 Research design
  • FIG. 2 Data collection techniques
  • FIG. 3 Primary research process
  • FIG. 4 Market sizing approach
  • FIG. 5 Forecasting model
  • FIG. 6 Global industry snapshot
  • FIG. 7 Industry ecosystem analysis
  • FIG. 8 Growth potential analysis, by product
  • FIG. 9 Growth potential analysis, by diseases indication
  • FIG. 10 Growth potential analysis, by distribution channel
  • FIG. 11 Porter's analysis
  • FIG. 12 PESTEL analysis
  • FIG. 13 Competitive analysis of major market players, 2022
  • FIG. 14 Competitive positioning matrix, 2022
  • FIG. 15 Strategic outlook matrix, 2022
目次
Product Code: 3994

Smart Inhalers Market size is set to expand at 8.6% CAGR from 2023-2032 attributed to the surging prevalence of respiratory conditions globally.

With the rising burden of conditions like asthma and chronic obstructive pulmonary disease (COPD), the demand for advanced respiratory care solutions, particularly smart inhalers, is surging. According to the 2023 CDC reports, COPD affects over 16 million individuals in the U.S. every year. Smart inhalers offer improved medication adherence through features, such as dosage reminders and real-time monitoring. Furthermore, with the healthcare landscape embracing telemedicine and remote patient monitoring, the market is set to gain significant momentum.

The industry is segmented into product, disease indication, distribution channel, and region.

Based on product, the MDI-based smart inhalers market gained significant traction in 2022 and is anticipated to witness 9.1% growth rate through 2032. MDI-based smart inhalers integrate technology with traditional inhalation devices for enhancing medication adherence and monitoring. These smart inhalers also facilitate real-time data tracking, dosage reminders, and personalized insights for patients for improving the overall respiratory management. The user-friendly nature of MDI devices combined with the benefits of digital connectivity will also contribute the segment growth.

In terms of distribution channel, the smart inhalers market from the e-commerce segment is projected to generate considerable revenue at 10% CAGR between 2023 and 2032 attributed to the rising burden of respiratory conditions and the increasing preference for convenient healthcare solutions. The ease of comparing products, reading user reviews, and obtaining information online is leading to enhanced consumer decision-making. Moreover, the rising trend of digital health and telemedicine is likely to fuel the segment expansion.

Regionally, the Europe smart inhalers industry is set to witness robust growth at 8.9% CAGR from 2023-2032. The presence of sophisticated healthcare infrastructure coupled with a high prevalence of respiratory diseases in the region is fostering the adoption of innovative respiratory care solutions. Additionally, the ongoing investments by pharmaceutical companies and technology firms for the development of smart inhalers integrated with digital technologies for effective management of asthma and COPD along with increased patient engagement initiatives will accelerate the regional industry expansion. For instance, in July 2023, Teva unveiled its new digitally enabled inhaler in the U.K. for patients suffering from asthma and COPD.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
  • 1.3 Forecast calculations
  • 1.4 Data Sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global smart inhalers market 360 degree synopsis, 2018 - 2032
  • 2.2 Regional trends
  • 2.3 Product trends
  • 2.4 Disease indication trends
  • 2.5 Distribution channel trends

Chapter 3 Smart Inhalers Industry Insights

  • 3.1 COVID- 19 impact analysis
  • 3.2 Industry ecosystem analysis
  • 3.3 Technology landscape
  • 3.4 Regulatory landscape
  • 3.5 Industry impact forces
    • 3.5.1 Growth drivers
      • 3.5.1.1 Growing prevalence of respiratory diseases across the globe
      • 3.5.1.2 Technological advancements in smart inhalers
      • 3.5.1.3 Increasing number of partnership agreements between pharma and software companies
      • 3.5.1.4 Increased medical adherence
    • 3.5.2 Industry pitfalls & challenges
      • 3.5.2.1 Dearth of awareness in developing countries
      • 3.5.2.2 Significant security risks and privacy issues
  • 3.6 Growth potential analysis
    • 3.6.1 By product
    • 3.6.2 By disease indication
    • 3.6.3 By distribution channel
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
    • 4.1.1 Adherium
    • 4.1.2 GlaxoSmithKline Plc
    • 4.1.3 Novartis AG
  • 4.2 Competitive analysis of major market players, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic outlook matrix, 2022

Chapter 5 Smart Inhalers Market Size and Forecast, By Product, 2018-2032 (USD Million)

  • 5.1 Key trends, by product
  • 5.2 Dry powder inhaler (DPI)-based smart inhalers
  • 5.3 Metered dose inhaler (MDI)-based smart inhalers

Chapter 6 Smart Inhalers Market Size and Forecast, By Disease Indication, 2018-2032 (USD Million)

  • 6.1 Key trends, by disease indication
  • 6.2 Asthma
  • 6.3 Chronic obstructive pulmonary diseases

Chapter 7 Smart Inhalers Market Size and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 7.1 Key trends, by distribution channel
  • 7.2 Hospital pharmacies
  • 7.3 Retail pharmacies
  • 7.4 E-commerce

Chapter 8 Smart Inhalers Market Size and Forecast, By Region, 2018-2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Turkey
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Adherium
  • 9.2 Propeller Health
  • 9.3 Nemera
  • 9.4 GlaxoSmithKline Plc.
  • 9.5 Novartis AG
  • 9.6 Aptar Group Inc.
  • 9.7 AstraZeneca Plc
  • 9.8 Findair Sp. Z.o.o.
  • 9.9 BioCorp
  • 9.10 Zeolr Technologies Pvt Ltd.
  • 9.11 Vectura Group Plc.
  • 9.12 Teva Pharmaceutical Industries Ltd.
  • 9.13 Boehringer Ingelheim International GmbH